https://www.selleckchem.com/pr....oducts/Vandetanib.ht
tient and graft survival. The typical immunosuppressive regimen of hematopoietic stem cell transplant includes cyclosporine. However, cyclosporine nephrotoxicity is a concern. We studied cyclosporine nephrotoxicity epidemiology in hematopoietic stem cell transplant patients and compared the pattern and urinary levels of the KIM-1 kidney injury molecule versus serum and urine creatinine levels. The study covered 10 months at Namazi Hospital, Shiraz, Iran. All patients met the following criteria 15 years old, received allogenic he